Connecta Therapeutics
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2025-06-01attributed |
| Founded | unknown |
| Headquarters | Spain |
| Industry | biotech |
| Stage | unknown |
| Website | connectatherapeutics.com |
CNS-focused biotech developing neuroplasticity modulators including lead asset CTH120 for neurodevelopmental disorders. Built around partnered or wholly-owned clinical programs. Spanish R&D-intensive biotech with CDTI backing.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-01 | grant | $2.7M | undisclosed |
Detected tech stack
WordPress 7.0, Apache HTTP Server, jQuery Migrate 3.4.1, Easy Pie Chart, parallax.js, Cookie Notice 3.0.6, Zepto, Bootstrap, PHP, MySQL, jquery 1.9.1, Chart.js
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | connectatherapeutics.com, read 2026-05-02 |
| Description | self-reported | connectatherapeutics.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.